29 related articles for article (PubMed ID: 8863792)
21. Synthesis and structure-activity relationship of pyrazolo[3,4-d]pyrimidines: potent and selective adenosine A1 receptor antagonists.
Poulsen SA; Quinn RJ
J Med Chem; 1996 Oct; 39(21):4156-61. PubMed ID: 8863792
[TBL] [Abstract][Full Text] [Related]
22. Pyrazolo-triazolo-pyrimidine derivatives as adenosine receptor antagonists: a possible template for adenosine receptor subtypes?
Baraldi PG; Cacciari B; Borean PA; Varanin K; Pastorin G; Da Ros T; Tabrizi MA; Fruttarolo F; Spalluto G
Curr Pharm Des; 2002; 8(26):2299-332. PubMed ID: 12369947
[TBL] [Abstract][Full Text] [Related]
23. Pyrazolo derivatives as potent adenosine receptor antagonists: an overview on the structure-activity relationships.
Cheong SL; Venkatesan G; Paira P; Jothibasu R; Mandel AL; Federico S; Spalluto G; Pastorin G
Int J Med Chem; 2011; 2011():480652. PubMed ID: 25954519
[TBL] [Abstract][Full Text] [Related]
24. Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists.
Redenti S; Ciancetta A; Pastorin G; Cacciari B; Moro S; Spalluto G; Federico S
Curr Top Med Chem; 2016; 16(28):3224-3257. PubMed ID: 27150365
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the Structure and Chemistry of 3(5)-Substituted Pyrazoles.
Secrieru A; O'Neill PM; Cristiano MLS
Molecules; 2019 Dec; 25(1):. PubMed ID: 31877672
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
